Search results
Results From The WOW.Com Content Network
In June 2023, Viatris was named to the Forbes Global 2000 list of the world's largest companies. [24] In October 2023, Viatris reached agreements to divest from almost all of its OTC business, its women’s healthcare business, and its India-based active pharmaceutical ingredients business for a total of about $3.6 billion. [25]
April – The Miss Supermodel Worldwide pageant will be held in the Philippines. [47] May 31 – Krishnah Gravidez will compete at Miss World 2024 in India. [49] June 28 – Tarah Valencia will compete at Miss Supranational 2025 in Poland. [50] November 29 – The Miss Tourism International 2025 pageant will be held in Davao City. [51]
Enfant Philippines Consumer goods Apparel retailers Manila: 1995 Baby goods and apparel P A ePLDT Ventus: Industrials Business support services Makati: 2001 Contact centers P A Fil-Asian Airways: Consumer services Airlines Cebu: 2011 Airline, defunct 2014 P D Filinvest: Conglomerates - Taguig: 1955 Real estate, hotels, tourism, banking P A
Dec. 2—Pfizer Inc. is starting to roll out the pharmaceutical company's biggest round of layoffs since 2009, and its Groton laboratories are not immune. Of course, New York-based Pfizer these ...
Considering this fantastic performance, investors have been wondering whether this big pharma company will launch a stock split. History shows us Lilly is open to such operations because it ...
This list is based on the Forbes Global 2000, which ranks the world's 2,000 largest publicly traded companies. The Forbes list takes into account a multitude of factors, including the revenue, net profit, total assets and market value of each company; each factor is given a weighted rank in terms of importance when considering the overall ...
“Big Pharma CEOs and their army of lobbyists spared no expense to defend a system rigged in their favor, prioritizing profits and price gouging over people’s health.
The company expects to be profitable in 2025. [ 2 ] In July 2023 due to a disappointing sales ramp-up of the recently approved sleep drug daridorexant , coupled with disappointing trial results in both clazosentan and lucerestat , Idorsia announced layoffs of up to five hundred staff of its one thousand two hundred total employees, to reduce ...